Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Items 101–200 of 999
Strain-level epidemiology of microbial communities and the human microbiome
Yan, Y., Nguyen, L. H., Franzosa, E. A., & Huttenhower, C. (2020) · Genome Medicine · doi:10.1186/s13073-020-00765-y · Cited by 166
Bowel Biofilms: Tipping Points between a Healthy and Compromised Gut?
Tytgat, H. L. P., Nobrega, F. L., van der Oost, J., & de Vos, W. M. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.08.009 · Cited by 144
Lü, L., Li, X., Zhong, W., Yang, M., Xu, M., Sun, Y., Ma, J., Liu, T., Song, X., Dong, W., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.021 · Cited by 163
Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis
Baumgartner, M., Lang, M., Holley, H., Crepaz, D., Hausmann, B., Pjevac, P., Moser, D., Haller, F., Hof, F., Beer, A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.024 · Cited by 157
The Role of the Gut Microbiota in Colorectal Cancer Causation
Hinai, E. A., Walton, G., & Commane, D. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215295 · Cited by 149
“[87] recently observed an abundance of biofilms co-colonised with BFT+ B.”
BackgroundGood Gone Bad: One Toxin Away From Disease for Bacteroides fragilis
Valguarnera, E., & Wardenburg, J. B. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.003 · Cited by 139
Intestinal microbiota and its association with colon cancer and red/processed meat consumption
Abu‐Ghazaleh, N., Chua, W. J., & Gopalan, V. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15042 · Cited by 170
Adaptation of the Gut Microbiota to Modern Dietary Sugars and Sweeteners
Rienzi, S. C. D., & Britton, R. A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz118 · Cited by 148
“In particular, biofilms have been implicated in colorectal cancer (107) and antibiotic resistance (108).”
BackgroundBacteriophages and their potential for treatment of gastrointestinal diseases
Duan, Y., Young, R., & Schnabl, B. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00536-z · Cited by 138
Microbial markers in colorectal cancer detection and/or prognosis
Villéger, R., Lopès, A., Véziant, J., Gagnière, J., Barnich, N., Billard, E., Boucher, D., & Bonnet, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2327 · Cited by 158
Context-dependent functions of pattern recognition receptors in cancer
Man, S. M., & Jenkins, B. J. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00462-5 · Cited by 151
Fusobacterium and Colorectal Cancer
Zhou, Z., Chen, J., Yao, H., & Hu, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00371 · Cited by 153
“In another paper, Dejea and colleagues studied patchy biofilms in colonic mucosa of patients with an APC gene mutations (128).”
BackgroundNext-generation probiotics – do they open new therapeutic strategies for cancer patients?
Kaźmierczak-Siedlecka, K., Skonieczna‐Żydecka, K., Hupp, T., Duchnowska, R., Marek-Trzonkowska, N. M., & Połom, K. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2035659 · Cited by 156
Intestinal bacteria and colorectal cancer: etiology and treatment
Dougherty, M. W., & Jobin, C. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185028 · Cited by 160
“coli dual association in Apc mice can be abrogated by the deletion of either bft or pks genes, respectively.(23) The recent identification of multiple genotoxins encoded by commensal bacteria isolated from IBD patients(18) suggests that there may be a plethora of similar interactions that remain to be discovered.”
BackgroundThe Gut Microbiome in Pancreatic Disease
Akshintala, V. S., Talukdar, R., Singh, V. K., & Goggins, M. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.045 · Cited by 131
“In the colon, adherent bacteria such as Bacteroides fragilis are thought to promote adenomas and cancers because they produce enterotoxins that have tumorigenic effects including effects on signaling, cell adhesion molecules, and cytokine alterations.(58,59) Consistent with their role in modulating the immune response…”
The role of microbiota in the development of colorectal cancer
Dai, Z., Zhang, J., Wu, Q., Chen, J., Liu, J., Wang, L., Chen, C., Xu, J., Zhang, H., Shi, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32017 · Cited by 129
“coli adhesion, triggering increased DNA damage in colonic epithelial cells by colibactin.(67) Bacteria-host cell contact is required for the genotoxic effect of pks; therefore, an environment where bacteria can more readily take root in the epithelial layer could deliver more of the pks product colibactin to host cell…”
BackgroundIL-17 in the Pathogenesis of Disease: Good Intentions Gone Awry
Majumder, S., & McGeachy, M. J. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-092536 · Cited by 149
Sun, F., Zhang, Q., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108590 · Cited by 162
Liu, W., Zhang, R., Shu, R., Yu, J., Li, H., Long, H., Jin, S., Li, S., Hu, Q., Yao, F., et al. (2020) · BioMed Research International · doi:10.1155/2020/7828392 · Cited by 154
“coli [25, 35], Parvimonas micra and Solobacterium moorei [26], Bacteroides fragilis [27, 36], Parvimonas micra and Peptostreptococcus [28, 37], Prevotella [38], Campylobacter jejuni [3], Faecalibacterium prausnitzii, Bifidobacterium, and lactobacillus genus [31].”
BackgroundColon Carcinogenesis: The Interplay Between Diet and Gut Microbiota
Loke, Y. L., Chew, M. T., Ngeow, Y. F., Lim, W. W.-D., & Peh, S. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603086 · Cited by 147
“, 2017), and Bacteroides fragilis (Boleij et al., 2015; Zhou et al., 2016; Purcell et al., 2017; Dejea et al., 2018; Kwong et al., 2018; Haghi et al., 2019) are differentially enriched in the fecal or colonic mucosa samples of CRC patients relative to healthy individuals, or in the CRC patient’s tumor tissue relative…”
BackgroundInfluentialMicrobiota Effects on Carcinogenesis: Initiation, Promotion, and Progression
Lopez, L. R., Bleich, R. M., & Arthur, J. C. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-080719-091604 · Cited by 149
Early diagnosis of lung cancer: which is the optimal choice?
Ning, J., Tao, G., Jiang, M., Jia, K., Wang, L., Li, W., Chen, B., Liu, Y., Wang, H., Zhao, S., et al. (2021) · Aging · doi:10.18632/aging.202504 · Cited by 165
Self-citationMicrobiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Rahman, M. M., Islam, M. R., Shohag, S., Ahasan, M. T., Sarkar, N., Khan, H., Hasan, A. M., Cavalu, S. D., & Rauf, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112898 · Cited by 142
Zhu, W., Miyata, N., Winter, M. G., Arenales, A., Hughes, E. R., Spiga, L., Kim, J., Sifuentes-Dominguez, L., Starokadomskyy, P., Gopal, P., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181939 · Cited by 124
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Miller, A. L., Bessho, S., Grando, K. C. M., & Tükel, Ç. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638867 · Cited by 141
“Furthermore, CPEC and ETBF were detected in patients with familial adenomatous polyposis, a premalignant disease that can develop into CRC (209).”
BackgroundCruz-Correa, M., Hylind, L. M., Marrero, J. H., Zahurak, M. L., Murray-Stewart, T., Casero, R. A., Montgomery, E. A., Iacobuzio-Donahue, C., Brosens, L. A., Offerhaus, G. J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.031 · Cited by 123
Self-citationHale, V. L., Jeraldo, P., Chen, J., Mundy, M., Yao, J., Priya, S., Keeney, G., Lyke, K., Ridlon, J., White, B. A., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0586-6 · Cited by 124
“fragilis and colorectal cancer [14, 46, 50], we next looked for the presence 353 of the B.”
BackgroundRoles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer
Hurtado, C. G., Wan, F., Housseau, F., & Sears, C. L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.056 · Cited by 130
Self-citationLiu, Q.-Q., Li, C.-M., Fu, L.-N., Wang, H.-L., Tan, J., Wang, Y.-Q., Sun, D.-F., Gao, Q.-Y., Chen, Y.-X., & Fang, J.-Y. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1788900 · Cited by 123
“Researchers have shown that mice implanted with ETBF and Escherichia coli are more likely to develop CRC and die.(7) Furthermore, ETBF might promote colorectal carcinogenesis by activating the nuclear factor kappa B (NF-κB) or Wnt signaling pathways,(8,9) increasing polyamine metabolism,(10) inducing DNA damage,(11) a…”
BackgroundSelf-citationBile salt hydrolase in non-enterotoxigenic Bacteroides potentiates colorectal cancer
Sun, L., Zhang, Y., Cai, J., Rimal, B., Rocha, E. R., Coleman, J. P., Zhang, C., Nichols, R. G., Luo, Y., Kim, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36089-9 · Cited by 140
Lopès, A., Billard, E., Casse, A. H., Villéger, R., Veziant, J., Roche, G., Carrier, G., Sauvanet, P., Briat, A., Pagès, F., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32920 · Cited by 119
“coli (CPEC) have been more frequently detected in colorectal adenocarcinoma and adenoma in comparison to nonneoplastic samples.(16,20,26,27) Most CPEC strains harbor colibactin-encoding polyketide synthase (pks) pathogenicity island (CoPEC, Colibactin-producing E.”
ResultMontalban‐Arques, A., & Scharl, M. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.050 · Cited by 129
“[28] Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, et al.”
BackgroundGut Microbiota in Intestinal and Liver Disease
Jones, R. M., & Neish, A. S. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-030320-095722 · Cited by 123
Colon Cancer in Young Adults: Trends and Their Implications
Weinberg, B. A., & Marshall, J. L. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0756-8 · Cited by 132
Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer
Irrazábal, T., Thakur, B. K., Kang, M., Malaisé, Y., Streutker, C., Wong, E. O. Y., Copeland, J. K., Gryfe, R., Guttman, D. S., Navarre, W. W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15549-6 · Cited by 126
Kordahi, M. C., Stanaway, I. B., Avril, M., Chac, D., Blanc, M.-P., Ross, B. D., Diener, C., Jain, S., McCleary, P., Parker, A., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.08.013 · Cited by 124
Arima, K., Zhong, R., Ugai, T., Zhao, M., Haruki, K., Akimoto, N., Lau, M. C., Okadome, K., Mehta, R. S., Väyrynen, J. P., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.054 · Cited by 110
Self-citationMolecular mechanisms in colitis-associated colorectal cancer
Zhou, R. W., Harpaz, N., Itzkowitz, S. H., & Parsons, R. E. (2023) · Oncogenesis · doi:10.1038/s41389-023-00492-0 · Cited by 140
The Cancer Microbiome: Recent Highlights and Knowledge Gaps
Knippel, R. J., Drewes, J. L., & Sears, C. L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0324 · Cited by 110
“coli and led to a coordinated increase in tumorigenesis compared to either bacteria alone (39).”
BackgroundSelf-citationTumorigenic bacteria in colorectal cancer: mechanisms and treatments
Li, S., Liu, J., Zheng, X., Ren, L., Yang, Y., Li, W., Fu, W., Wang, J., & Du, G. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0651 · Cited by 147
Intracellular bacteria in cancer—prospects and debates
Schorr, L., Mathies, M., Elinav, E., & Puschhof, J. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00446-9 · Cited by 121
Immunity, microbiota and kidney disease
Knauf, F., Brewer, J. R., & Flavell, R. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0118-7 · Cited by 124
Sun, J., Chen, F., & Wu, G. (2023) · The ISME Journal · doi:10.1038/s41396-023-01483-0 · Cited by 127
Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome
Barrett, M., Hand, C. K., Shanahan, F., Murphy, T., & O’Toole, P. W. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.019 · Cited by 108
Massip, C., Branchu, P., Bossuet-Greif, N., Chagneau, C. V., Gaillard, D., Martin, P., Boury, M., Sécher, T., Dubois, D., Nougayrède, J.-P., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1008029 · Cited by 107
“coli were overrepresented in colorectal cancer biopsies compared to controls [33,34,61].”
BackgroundChan, J. L., Wu, S., Geis, A. L., Chan, G. V., Gomes, T. A. M., Beck, S. E., Wu, X., Fan, H., Tam, A. J., Chung, L., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0085-5 · Cited by 113
Self-citationSnider, E. J., Compres, G., Freedberg, D. E., Khiabanian, H., Nobel, Y. R., Stump, S., Uhlemann, A., Lightdale, C. J., & Abrams, J. A. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0008 · Cited by 121
“Colibactin-producing Escherichia coli promote tumor growth in xenograftmousemodels (30),modify the tumor microenvironment (31), and have been found in high abundance in colonic biofilms in patients with familial adenomatous polyposis (32).”
BackgroundSethi, V., Vitiello, G. A., Saxena, D., Miller, G., & Dudeja, V. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.045 · Cited by 104
Morphological instability and roughening of growing 3D bacterial colonies
Martínez-Calvo, A., Bhattacharjee, T., Bay, R. K., Luu, H. N., Hancock, A. M., Wingreen, N. S., & Datta, S. S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208019119 · Cited by 106
“10 10 10 (1) (2) (3) (4) (5) (6) (7) (8) (9) 10 1”
Gut–liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice
Wang, X., Fang, Y., Liang, W., Cai, Y., Wong, C. C., Wang, J., Wang, N., Lau, H. C.-H., Jiao, Y., Zhou, X., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-024-01890-9 · Cited by 128
Tettamanti Boshier, F. A., Srinivasan, S., Lopez, A., Hoffman, N. G., Proll, S., Fredricks, D. N., & Schiffer, J. T. (2020) · mSystems · doi:10.1128/msystems.00777-19 · Cited by 97
The Canonical Wnt Pathway Drives Macropinocytosis in Cancer
Redelman-Sidi, G., Binyamin, A., Gaeta, I., Palm, W., Thompson, C. B., Romesser, P. B., Lowe, S. W., Bagul, M., Doench, J. G., Root, D. E., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3199 · Cited by 94
Role of the microbiome in occurrence, development and treatment of pancreatic cancer
Wang, Y., Yang, G., You, L., Yang, J., Feng, M., Qiu, J., Zhao, F., Liu, Y., Cao, Z., Zheng, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1103-2 · Cited by 102
Advances of Wnt Signalling Pathway in Colorectal Cancer
Zhu, Y., & Li, X. (2023) · Cells · doi:10.3390/cells12030447 · Cited by 110
“Intestinal microbiota activate the pathogen recognition receptors PRR9 to induce innate immune responses and activate the inflammatory response mediated by transcription factor IRF3 and NFκB [56].”
BackgroundGut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 99
“coli enhances DNA damage through oncotoxins, and the two synergistically promote the carcinogenesis of colonic EC.(171) Fusobacterium nucleatum was reported to activate the NF‐κB pathway through TLR4 recognition, leading to the subsequent upregulation of microRNA‐21.”
BackgroundInfluentialBifidobacterium Strain-Specific Enhances the Efficacy of Cancer Therapeutics in Tumor-Bearing Mice
Yoon, Y., Kim, G., Jeon, B., Fang, S., & Park, H. (2021) · Cancers · doi:10.3390/cancers13050957 · Cited by 99
Microbiota-driven mechanisms at different stages of cancer development
Ivleva, E., & Grivennikov, S. I. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100829 · Cited by 103
“Mice with colonic biofilms containing Escherichia coli and enterotoxigenic Bacteroides fragilis showed increased DNA damage in colonic epithelium and production of IL-17 which was associated with faster tumor onset, progression and greater mortality [21] .”
BackgroundAlves, N. D. O., Dalmasso, G., Nikitina, D., Vaysse, A., Ruez, R., Ledoux, L., Pédron, T., Bergsten, E., Boulard, O., Autier, L., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2320291 · Cited by 107
“55 clbB F: 5’-GCGCATCCTCAAGAGTAAATA-3’ R: 5’-GCGCTCTATGCTCATCAACC-3’ Probe: 5’ FAM-TATTCGACACAGAACA ACGCCGGT-TAM 3’ Dejea et al .”
Doocey, C. M., Finn, K., Murphy, C. P., & Guinane, C. M. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02465-6 · Cited by 110
Relationship between mucosa-associated gut microbiota and human diseases
Juge, N. (2022) · Biochemical Society Transactions · doi:10.1042/bst20201201 · Cited by 104
Inamura, K., Hamada, T., Bullman, S., Ugai, T., Yachida, S., & Ogino, S. (2022) · Gut · doi:10.1136/gutjnl-2022-327209 · Cited by 100
Bacterial biofilms in the human body: prevalence and impacts on health and disease
Perry, E. K., & Tan, M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1237164 · Cited by 117
“, 2020), and such bacteria were enriched in biofilms adhering to pre-cancerous lesions in patients with familial adenomatous polyposis (Dejea et al., 2018).”
BackgroundMicrobiome distinctions between the CRC carcinogenic pathways
DeDecker, L. C., Coppedge, B., Avelar‐Barragan, J., Karnes, W. E., & Whiteson, K. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1854641 · Cited by 93
The human microbiome and cancer: a diagnostic and therapeutic perspective
Kandalai, S., Li, H., Zhang, N., Peng, H., & Zheng, Q. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2240084 · Cited by 101
“fragilis toxin, respectively.(25) On the other hand, B.”
BackgroundYang, Y., Gharaibeh, R. Z., Newsome, R. C., & Jobin, C. (2020) · Nature Cancer · doi:10.1038/s43018-020-0078-7 · Cited by 98
Barlow, J. T., Leite, G., Romano, A. E., Sedighi, R., Chang, C. Y.-Y., Celly, S., Rezaie, A. R., Mathur, R., Pimentel, M., & Ismagilov, R. F. (2021) · Microbiome · doi:10.1186/s40168-021-01162-2 · Cited by 99
“Previous mutualistic relationships between aerobic and anaerobic species that could help facilitate colonization have been observed in other studies with Bacteroides fragilis and either Klebsiella pneumonia or Escherichia coli [51, 52].”
ResultIRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of β-catenin
Tian, M., Wang, X., Sun, J., Lin, W., Chen, L., Liu, S., Wu, X., Shi, L., Xu, P., Cai, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19627-7 · Cited by 90
Self-citationColibactin-driven colon cancer requires adhesin-mediated epithelial binding
Jans, M., Kolata, M., Blancke, G., D’Hondt, A., Gräf, C., Ciers, M., Sze, M., Thiran, A., Petta, I., Andries, V., et al. (2024) · Nature · doi:10.1038/s41586-024-08135-z · Cited by 84
Effects of a Novel Probiotic Combination on Pathogenic Bacterial-Fungal Polymicrobial Biofilms
Hager, C. L., Isham, N. C., Schrom, K. P., Chandra, J., McCormick, T. S., Miyagi, M., & Ghannoum, M. A. (2019) · mBio · doi:10.1128/mbio.00338-19 · Cited by 89
“(39) identified biofilms composed predominantly of E.”
Wu, M., Li, J., An, Y., Li, P., Xiong, W., Li, J., Yan, D., Wang, M., & Zhong, G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02101 · Cited by 88
“The intestinal Turicibacter population, which was previous shown to be a strong indicator of wild-type mice, exhibited low competitiveness and was unable to persist in the altered gut resulting from CD45 inactivation (Dimitriu et al., 2013).”
BackgroundThe Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
Smet, A., Kupčinskas, J., Link, A., Hold, G. L., & Bornschein, J. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.013 · Cited by 94
Genetic and epigenetic dependencies in colorectal cancer development
Parmar, S., & Easwaran, H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac035 · Cited by 99
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 117
Kosumi, K., Hamada, T., Koh, H., Borowsky, J., Bullman, S., Twombly, T. S., Nevo, D., Masugi, Y., Liu, L., da Silva, A., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.08.015 · Cited by 91
Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer
Gerner, E. W., Bruckheimer, E., & Cohen, A. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.003343 · Cited by 96
“Relevance of polyamines to the extracolonic sequelae of APC mutations The high penetrance of APC mutations in FAP results in nearly 100% of patients developing colon and rectal cancer if they retain their colons and rectums.”
BackgroundInfluentialNougayrède, J.-P., Chagneau, C. V., Motta, J.-P., Bossuet-Greif, N., Belloy, M., Taieb, F., Gratadoux, J.-J., Thomas, M., Langella, P., & Oswald, E. (2021) · mSphere · doi:10.1128/msphere.00624-21 · Cited by 82
“Inflammation and dysbiosis are also known to allow the expansion of the E. coli population, including that of Nissle 1917, alongside the epithelium (Cevallos et al., 2019; Dejea et al., 2018; Zhu et al., 2019).”
BackgroundTumor hijacks macrophages and microbiota through extracellular vesicles
Jiang, J., Mei, J., Ma, Y., Jiang, S., Zhang, J., Yi, S., Feng, C., Liu, Y., & Liu, Y. (2022) · Exploration · doi:10.1002/exp.20210144 · Cited by 91
Xiang, Y., Zhang, C., Wang, J., Cheng, Y., Wang, L., Tong, Y., & Yan, D. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04335-9 · Cited by 93
“…of FAP patients, demonstrating that intestinal flora can form biofilms that induce upregulation of colonic epithelial interleukin 17 expression, causing abnormal alteration of colonic epithelial DNA, heterogeneous proliferation of epithelial cells, and subsequent progression to malignant tumor [6].”
BackgroundRizzato, C., Torres, J., Kasamatsu, E., Camorlinga‐Ponce, M., Bravo, M. M., Canzian, F., & Kato, I. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00846 · Cited by 89
“They were rather patchy (as opposed to continuous as observed for sporadic cases) and primarily composed of Bf and polyketide-peptide genotoxin producing pks island positive Escherichia coli, with little periodontal pathogens (Dejea et al., 2018).”
BackgroundGabuzda, D. H., Jamieson, B. D., Collman, R. G., Lederman, M. M., Burdo, T. H., Deeks, S. G., Dittmer, D. P., Fox, H. S., Funderburg, N., Pahwa, S. G., et al. (2020) · Pathogens and Immunity · doi:10.20411/pai.v5i1.365 · Cited by 89
“Many of these findings involve pathways mediated by systemic inflammation and/or microbial metabolite alterations, although local microbiome populations have also been implicated in development of cancers and lung disease [74-76].”
BackgroundFidelle, M., Yonekura, S., Picard, M., Cogdill, A., Hollebecque, A., Roberti, M. P., & Zitvogel, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600886 · Cited by 81
Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China
Qi, Y.-F., Sun, J., Ren, L., Cao, X.-L., Dong, J.-H., Tao, K. X., Guan, X., Cui, Y.-N., & Su, W. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5411-y · Cited by 82
Increased Epithelial Oxygenation Links Colitis to an Expansion of Tumorigenic Bacteria
Cevallos, S. A., Lee, J., Tiffany, C. R., Byndloss, A. J., Johnston, L., Byndloss, M. X., & Bäumler, A. J. (2019) · mBio · doi:10.1128/mbio.02244-19 · Cited by 93
Shining a Light on Colibactin Biology
Dougherty, M. W., & Jobin, C. (2021) · Toxins · doi:10.3390/toxins13050346 · Cited by 80
“coli populations, and a concomitant increase in γH2AX histological staining and tumor burden relative to monoassociation [58].”
BackgroundIntratumor microbiome in cancer progression: current developments, challenges and future trends
Liu, J., & Zhang, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00381-5 · Cited by 80
“fragilis [34] and Fusobacterium [70] are increased, whereas those of Ruminococcus, Bifidobacterium, and Streptococcus species are decreased [87].”
BackgroundInfluentialAPC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures
Morcrette, G., Hirsch, T. Z., Badour, E., Pilet, J., Caruso, S., Caldéraro, J., Martin, Y., Imbeaud, S., Letouzé, É., Rebouissou, S., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1583547 · Cited by 87
“Frozen tumor and non-tumor liver tissues were available in 4/12 APC-HB and all the control non-APC-HB.”
BackgroundInfluentialZhang, X., Chen, X., Guo, Y., Gao, G., Wang, D., Wu, Y., Liu, J., Liang, G., Zhao, Y., & Wu, F. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102059 · Cited by 79
“Driver-passenger” bacteria and their metabolites in the pathogenesis of colorectal cancer
Avril, M., & DePaolo, R. W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1941710 · Cited by 81
Gut microbiome in gastrointestinal cancer: a friend or foe?
Liu, Y., Baba, Y., Ishimoto, T., Gu, X. J., Zhang, J., Nomoto, D., Okadome, K., Baba, H., & Qiu, P. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69331 · Cited by 85
“fragilis damage double-stranded DNA and promote cellular inflammation and oncogenic mutation [81, 82].”
BackgroundJoo, J. E., Chu, Y. L., Georgeson, P., Walker, R., Mahmood, K., Clendenning, M., Meyers, A. L., Como, J., Joseland, S. L., Preston, S., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-023-02554-x · Cited by 94
Burgos-Molina, A. M., Santana, T. T., Redondo, M., & Romero, M. J. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116188 · Cited by 101
“ETBF also orchestrates the recruitment of other bacterial species to form biofilms that coat colorectal adenomas and tumors [107], thereby initiating a proinflammatory cascade within colonic epithelial cells, thus facilitating the progression of CRC [108].”
BackgroundLactylation in cancer: Mechanisms in tumour biology and therapeutic potentials
He, Y., Song, T., Ning, J., Wang, Z., Yin, Z., Jiang, P., Yuan, Q., Yu, W., & Fan, C. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70070 · Cited by 96
Epidemiology and biology of early onset colorectal cancer
Venugopal, A., & Carethers, J. M. (2022) · EXCLI journal · doi:10.17179/excli2021-4456 · Cited by 114
“…carcino- genesis through altering colonic integrity affecting systemic inflammatory responses, through toxin production, and through metabolic products of short chain fatty acids (SCFAs) and alterations in bile acid composition (Abdullah et al., 2021; Okita et al., 2020; Dejea et al., 2018).”
BackgroundInflammatory bowel disease and carcinogenesis
Nagao‐Kitamoto, H., Kitamoto, S., & Kamada, N. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10028-4 · Cited by 86
“coli in the gut, and induces epithelial damage as mentioned [125].”
BackgroundFecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yang, Y., An, Y., Dong, Y., Chu, Q., Wei, J., Wang, B., & Cao, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104967 · Cited by 90
Zhu, S., Wang, X., Li, S., Liu, L., & Li, L. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c00310 · Cited by 75
Sun, X., Zhao, D.-Y., Zhou, Y.-C., Wang, Q., Qin, G., & Yao, S. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i45.7173 · Cited by 82
Straková, N., Kořená, K., & Karpíšková, R. (2021) · Toxicon · doi:10.1016/j.toxicon.2021.04.007 · Cited by 83
Chen, S., Fan, L., Lin, Y., Qi, Y., Xu, C., Ge, Q., Zhang, Y., Wang, Q., Jia, D., Wang, L., et al. (2023) · 癌症:英文版 · doi:10.1002/cac2.12469 · Cited by 76
“Some “CRC-promoting” bacteria have been studied in CRC, such as Fusobacterium nucleatum [6–8], Peptostreptococcus anaerobius [9], and Bacteroides fragile [10, 11].”
BackgroundDuncan, K., Carey-Ewend, K., & Vaishnava, S. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1874815 · Cited by 73
“studies that associate intestinal biofilms with pathogenic phenotypes such as IBD and colon cancer (13, 46).”
Background
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.